Have you or your loved ones been diagnosed with cardiogenic shock?

You may be eligible to participate in a cardiogenic shock clinical trial.

Have you or your loved ones been diagnosed with cardiogenic shock? You may be eligible to participate in a cardiogenic shock clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Cardiogenic Shock Clinical Trial in Seoul City Seoul

NCT02985008 | Observational patient registry

Have you or your loved ones been diagnosed with cardiogenic shock?

You may be eligible to participate in a cardiogenic shock clinical trial.

Have you or your loved ones been diagnosed with cardiogenic shock? You may be eligible to participate in a cardiogenic shock clinical trial.

Recruiting

Male & Female

19 Years +

This study is looking to recruit 1000 Participants

Retrospectively and prospectively enrolled patients with cardiogenic shock in domestic manifolds and investigated the current state of treatment and clinical features of cardiogenic shock in Koreans and identified the factors that could improve the prognosis and the use of IABP and ECMO And to investigate its therapeutic effect.

Show me more details

Details for the study

Population

Total: 1,000 - Cardiogenic shock group with inserted IABP, ECMO : 400 - Cardiogenic shock group without inserted IABP, ECMO : 600

Brief Title

Clinical Outcomes and Efficacy of Left Ventricular Assist Device for Korean Patients With Cardiogenic Shock

Official Title

SMart Angioplasty Research Team: A Multi-center, Open, REtrospective and Prospective Observational Study to Investigate Clinical oUtcomes and Efficacy of Left Ventricular Assist Device for Korean Patients With Cardiogenic Shock : RESCUE

Brief Summary

Retrospectively and prospectively enrolled patients with cardiogenic shock in domestic<br /> manifolds and investigated the current state of treatment and clinical features of<br /> cardiogenic shock in Koreans and identified the factors that could improve the prognosis and<br /> the use of IABP and ECMO And to investigate its therapeutic effect.

Detailed Description

1. The selection / exclusion criteria for persons with cardiogenic shock should be verified
by medical records from January 1, 2014 before the approval date of each institution's
clinical trial screening committee.

2. If a cardiogenic shock to the selection criteria is found in the emergency room, general
ward, or intensive care unit of the participating institutions, enroll in this study and
fill in the information according to the e-CRF.

3. After 1, 6 and 12 months, visit the hospital for examination and procedures. The person
in charge of the examination or the delegate of the examiner may follow the person by
telephone or an outpatient visit.

Study Criteria

Inclusion Criteria:

  1. 19 years old or older

  2. ① Systolic blood pressure is less than 90mmHg for more than 30 minutes despite the
     fluid therapy, or Use of pressure boosting agents is necessary.

     ② Peripheral hypopnea (cold skin, urine less than 30 cc per hour, impaired
     consciousness, lactate ≥2.0 mmol / l) or a person with pulmonary edema.

  3. Causes of cardiogenic shock include acute myocardial infarction (including in coronary
     intervention), cardiomyopathy, myocarditis, pulmonary embolism, refractory ventricular
     tachycardia, shock during coronary intervention.

  4. Those voluntarily consenting to the medical records and the data necessary for the
     study during the entire study period.

Exclusion Criteria:

  1. Other causes except for cardiogenic shock (low blood pressure, septic, obstructive
     shock)

  2. Shock with cardiac arrest outside the hospital

  3. People with allergic reactions to anticoagulants such as heparin.

  4. Those who refused active treatment.